 |
|
|
|
|
|
Treatment Next 25
|
|
Location |
|
Last Updated |
|
|
|
Details |
|
Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM) |
|
Graz, Austria
Hamburg, Germany
Kiel, Germany
Milan, Italy
Milan, Italy
Tel Aviv, Israel
San Diego, CA
Orlando, FL
Chicago, IL
Scarborough, ME
Edison, NJ
New York, NY
Danville, PA
Pittsburgh, PA
Dallas, TX |
|
09/30/2009 |
|
|
|
|
|
Details |
|
A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides in Combination with Poly-ICLC for Children with Newly Diagnosed Malignant or Intrinsic Brain Stem Gliomas (BSG) or Incompletely Resected Non-Brainstem High-Grade Gliomas (HGG) or Recurrent Unresectable Low-Grade Gliomas (LGG) or Recurrent High Grade Gliomas |
|
Pittsburgh, PA |
|
09/23/2009 |
|
|
|
Details |
|
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor |
|
Boston, MA |
|
09/06/2009 |
|
|
|
|
|
Details |
|
Phase I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
|
|
Durham, NC |
|
09/05/2009 |
|
|
|
Details |
|
Phase I/II Trial for Patients with Recurrent Resectable Glioblastoma Multiforme Using Surgery with Implantable BCNU Polmer Followed by Post-operative Irinotecan and Bevacizumab |
|
Cincinnati, OH |
|
08/27/2009 |
|
|
|
|
|
Details |
|
RTOG 0825 Phase III Double-Blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab versus Conventional Concurrent |
|
Cincinnati, OH |
|
08/27/2009 |
|
|
|
Details |
|
Phase 1 Study of Azixa (MPC-6827) and Carboplatin in Recurrent/Relapsed Glioblastoma Multiforme |
|
Los Angeles, CA
Atlanta, GA
New York, NY
Houston, TX
Salt Lake City, UT |
|
08/11/2009 |
|
|
|
|
|
Details |
|
Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme |
|
Los Angeles, CA
Stanford, CA
Chicago, IL
Boston, MA
Burlington, MA
Worcester, MA
Lebanon, NH
New York, NY |
|
08/11/2009 |
|
|
|
Details |
|
ABTC07-01-Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant
Temozolomide in Patients with Malignant Glioma |
|
San Francisco, CA |
|
07/07/2009 |
|
|
|
|
|
Details |
|
PHASE II, single-arm, open-label investigation of HSPPC-96 vaccine with concurrent temozolomide in patients with newly diagnosed Glioblastoma Multiforme |
|
San Francisco, CA |
|
07/07/2009 |
|
|
|
Details |
|
A Phase 2 Study of XL184 in Subjects with Progressive or Recurrent Glioblastoma Multiforme in First or Second Relapse |
|
San Francisco, CA
Charlottesville, VA |
|
06/29/2009 |
|
|
|
|
|
Details |
|
Phase II Clinical Trial of Hyperbaric Oxygenation in Conjunction with Radiotherapy and Temozolomide in Adults with Newly Diagnosed Glioblastoma |
|
Mineola, NY |
|
06/18/2009 |
|
|
|
Details |
|
A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
|
|
Details |
|
A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
Details |
|
A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
|
|
Details |
|
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
Details |
|
Phase II Trial of Tamoxifen and Bortezomib in Patients With Recurrent High-Grade Gliomas
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
|
|
Details |
|
A Feasibility Assessment and a Phase I/II Trial of MLN518 (Tandutinib) for Treatment of Patients with Recurrent Glioblastoma |
|
Birmingham, AL
Tampa, FL
Atlanta, GA
Boston, MA
Baltimore, MD
Bethesda, MD
Detroit, MI
Winston-Salem, NC
Cleveland, OH
Philadelphia, PA |
|
04/21/2009 |
|
|
|
Details |
|
A Phase II Clinical Trial of the Histone Deacetylase Inhibitor Valproic Acid in Combination With Temodar and Radiation Therapy in Patients With High Grade Gliomas
|
|
Bethesda, MD |
|
04/21/2009 |
|
|
|
|
|
Details |
|
A Phase II Trial of Bevacizumab (avastin) and Irinotecan (CPT-11) for Patients With Recurrent High-Grade Gliomas Immediately Following Tumor Progression After Treatment With Bevacizumab Alone: A Companion Trial to NCI Study 06-C-0064 (Bevacizumab Alone for Recurrent Gliomas)
|
|
Bethesda, MD |
|
04/21/2009 |
|
|
|
Details |
|
A Phase II Trial of Enzastaurin in Combination With Bevacizumab in Adults With Recurrent Malignant Gliomas
|
|
Bethesda, MD |
|
04/21/2009 |
|
|
|
|
|
Details |
|
Phase II Trial of Bevacizumab (Avastin)for Patients With Recurrent High-Grade Glioma |
|
Bethesda, MD |
|
04/21/2009 |
|
|
|
Details |
|
A Pharmacokinetic and Phase 2 Study of Sunitinib Malate in Recurrent Malignant Gliomas |
|
Toronto, Ontario, CANADA
Bethesda, MD
New York, NY
Cincinnati,, OH
Columbus, OH |
|
04/21/2009 |
|
|
|
|
|
Details |
|
An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-Grade Glioma |
|
Bethesda, MD |
|
04/15/2009 |
|
|
|
Details |
|
Phase I Trial of Conditionally Replication-Competent Adenovirus (Delta-24-RGD4C) for recurrent malignant glioma |
|
Houston, TX |
|
04/14/2009 |
|
|
|
|
|
